An interventional study of Gradual increase of force in Canine Retraction, sponsored by Cairo University. Status unknown at 1 site in Egypt. Open to participants aged 16 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-12-08.
Sponsored by Cairo University · Not applicable, Interventional, and Other
Therefore the aim of the current randomized controlled clinical trial is to investigate the effect of gradually increasing force magnitude versus constant force magnitude on the rate of tooth movement in a canine retraction model, furthermore investigate the effect of the two force systems on the ratio of cytokines and the pain experienced by the patient.
Research question:
In adult orthodontic patients requiring bilateral maxillary canines retraction, will gradually increasing force magnitudes accelerate the rate of canine retraction in the experimental side when compared to the control side?
A. -Patient preparation:
B. Canine Retraction:
Cairo University is the lead sponsor of 4,909 studies on the registry; 1,445 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Control Group
Active Group
Other: Gradual increase of force
steady force
Also known as: 150 gm
Rate of canine retraction
mm/time
Time frame: 4 months
change on the Cytokine levels in the gingival crevicular fluid
ratio
Time frame: 3 months
The effect of gradually increasing force magnitude on Pain
numeric Pain scale ( 0 as no Pain - 10 As maximum Pain)
Time frame: 4 months
Plan to share: No
This study is status unknown, as verified in Dec 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.